cape town

Panel Discussion: Totally Drug Resistant TB Is Here: Are We Too Late? || HGHI


 

Panel Discussion: Totally Drug Resistant TB is here: Are we too late? || HGHI – Barry Bloom, Ph.D., Harvard School of Public Health (Chair); Sarah Fortune, MD, Harvard School of Public Health; Jeremy Greene, MD, Ph.D., Harvard Medical School; Bob Horsburgh, Ph.D., Boston University; Khisimuzi Mdluli, Ph.D., TB Alliance; Scott Podolsky, MD, Harvard Medical School; Zarir Udwadia, MD, Hunduja National Hospital, Mumbai; and Rob Warren, Ph.D., Stellenbosch University, Cape Town A topical discussion to answer how we have arrived at TDR; to discuss new drugs in the pipeline; to consider the ethical and policy considerations surrounding patient treatment; to predict the spread of TDR, and to mobilize our community to devise a strategy to cure people infected with TDR TB. Sixth Annual New England Tuberculosis Symposium Harvard Global Health Institute June 28th, 2012 The Broad Institute 7 Cambridge Center Cambridge, MA

 

Genomic sequencing identifies mutant 'drivers' of common brain tumor

Filed under: drug treatment centers in massachusetts

Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15 percent of brain tumors known as meningiomas, a finding that could lead to the first effective drug treatments for the tumors, report scientists from Dana …
Read more on HealthCanal.com

 

All Things Appy: 5 Top iOS Health and Fitness Apps

Filed under: drug treatment centers in massachusetts

"The more food records people kept, the more weight they lost," said Jack Hollis, M.D., of Kaiser Permanente's Center for Health Research, in a comment on the MyFitnessPal website. "Those who kept daily food records [lost] twice … Checking symptoms …
Read more on TechNewsWorld

 

NCCN Guidelines® Recommend NovoTTF™ Therapy as a Standard Treatment

Filed under: drug treatment centers in massachusetts

… Food and Drug Administration (FDA) approved the NovoTTF™-100A System for use as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM), following histologically – or radiologically …
Read more on Melodika.net (press release)